Clinical Trial

Exercise Prescription in Cardiac Rehabilitation Mediated by Autonomic Function

Study acronym: EXCARMA
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Cardiac rehabilitation (CR) is an essential secondary prevention component in the treatment of cardiovascular diseases and one of the most cost- effective clinical interventions. Exercise training (ET) in CR programs (CRP) has unequivocal benefits in the reduction of cardiovascular adverse events, by decreasing the overactivated sympathetic tone. This ET added value can be measured by variables that express autonomic control using indirect (standard) or direct (experimental) methodologies. Direct autonomic assessment (ex. Microneurography) is accurate but unusable in daily practice, whereas standard indirect autonomic assessment using clinical parameters is imprecise, resulting in underprescription to safeguard patient safety, with less benefit to the patients. In this project, we aim to apply Machine Learning models to a set of indirect and direct variables, to make a multivariate correlation analysis and so define a normalization factor for exercise prescription.
Trial Details
NCT Number NCT07288840
Lead Sponsor Instituto Politécnico de Leiria
Collaborators: Universidade do Minho - ICVS, Hospital de Santo André, Fundação para a Ciência e a Tecnologia
Conditions Cardiac Rehabilitation, Exercise Therapy, Autonomic Nervous System Imbalance, Treatment Outcomes
Enrollment 90 participants
Start Date 2024-01-02
Primary Completion 2025-12 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-17